MCRB - Seres Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-250,157
-250,157
-65,578
-89,127
-70,279
Depreciation & amortization
6,629
6,629
5,947
6,578
7,603
Stock based compensation
25,482
25,482
20,222
8,824
8,344
Change in working capital
-18,391
-18,391
41,530
-23,197
-24,627
Accounts receivable
0
0
9,387
-7,602
-1,785
Accounts Payable
2,203
2,203
9,362
-1,159
-1,460
Other working capital
-238,637
-238,637
-2,878
-94,201
-77,522
Other non-cash items
6,933
6,933
2,041
3,312
2,336
Net cash provided by operating activites
-228,816
-228,816
6,688
-93,610
-76,520
Cash flows from investing activities
Investments in property, plant and equipment
-9,821
-9,821
-9,566
-591
-1,002
Purchases of investments
-48,221
-48,221
-95,971
-218,284
-46,420
Sales/Maturities of investments
140,470
140,470
169,625
59,984
16,904
Net cash used for investing activites
82,428
82,428
64,088
-158,891
-30,518
Cash flows from financing activities
Debt repayment
-1,907
-1,907
-948
-
-
Common stock issued
101,168
101,168
0
268,641
61,215
Common stock repurchased
-
-
-
0
0
Other financing activites
-
-
-
19,900
-425
Net cash used privided by (used for) financing activities
129,602
129,602
1,178
303,424
86,231
Net change in cash
-16,786
-16,786
71,954
50,923
-20,807
Cash at beginning of period
188,002
188,002
116,049
65,126
85,933
Cash at end of period
171,215
171,215
188,002
116,049
65,126
Free Cash Flow
Operating Cash Flow
-228,816
-228,816
6,688
-93,610
-76,520
Capital Expenditure
-9,821
-9,821
-9,566
-591
-1,002
Free Cash Flow
-238,637
-238,637
-2,878
-94,201
-77,522